资讯

FDA commissioner stirs debate over hormone therapy for menopause
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
Everyday Health on MSN1 天
New FDA Panel Recommends Removing Warnings From Estrogen Therapies for Menopause
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
Healio6 天
FDA panel calls for label changes, more education on menopausal hormone therapy
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
BioPharma Dive5 天
Panel urges FDA to remove warnings on hormonal menopause therapy
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
The FDA May Finally Remove The Black Box Warning On Hormone Therapy Products. Here’s When ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
FierceBiotech2 年
Astellas' menopause therapy accepted for FDA review - Fierce Biotech
Astellas’ menopause treatment has been accepted for FDA review, five months after the therapy hit a speed bump in a phase 3 trial conducted in Asia.
Science News5 天
U.S. FDA may nix black box warning on some menopause estrogen treatments
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
BizPac Review1 天
‘All of us are begging’: New push for FDA to remove ‘black box’ warnings from ...
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
Managed Healthcare Executive6 天
FDA Panel Challenges Hormone Replacement Therapy Risks
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
Seeking Alpha2 年
FDA extends review period of Astellas fezolinetant to treat menopause ...
The U.S. Food and Drug Administration (FDA) extended review period by three months of Astellas Pharma's (ALPMF) (ALPMY) fezolinetant to treat moderate to severe vasomotor symptoms ...